Kure Kyosai Hospital

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• High blood pressure3 trials
• Pulmonary arterial hypertension3 trials
• Crohn's disease1 trial
• Ulcerative colitis1 trial

Phase

• Phase 34 trials
• Phase 2/31 trial

Status

• Active, not recruiting3 trials
• Completed1 trial
• Terminated1 trial

Lead sponsor

• Actelion3 trials
• Janssen Research & Development, LLC2 trials

Running trials

• Active, not recruiting

  A Study of Guselkumab Subcutaneous Therapy in Participants With Moderately to Severely Active Crohn's Disease

  NCT05197049· Phase 3· Janssen Research & Development, LLC· Source

• Active, not recruiting

  Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension

  NCT04273945· Phase 3· Actelion· Source

• Active, not recruiting

  A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis

  NCT04033445· Phase 2/3· Janssen Research & Development, LLC· Source

Closed trials

• Terminated

  A Study to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension

  NCT04271475· Phase 3· Actelion· Source

• Completed

  Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)

  NCT03904693· Phase 3· Actelion· Source